Division of Infectious Diseases Archive — Page 2 of 13
-
January 13, 2025
VUMC’s Kelly Dooley joins clinical pharmacology board
ASCPT counts itself the largest scientific and professional organization serving the disciplines of clinical pharmacology and translational science. -
October 21, 2024
Anna Person honored for teaching by Infectious Diseases Society of America
Person, an award citation reads in part, “has been a champion for empathy and equity in caring for patients. ... She models for her learners how to compassionately care.” -
October 16, 2024
Study of severe drug reactions finds skin cells activate their own assassins
Single-cell analysis reveals the inner workings of the life-threatening adverse drug reactions Stevens-Johnson syndrome and toxic epidermal necrolysis. -
September 11, 2024
Kelly Dooley’s TB research receives MERIT Award from the NIH
Researchers must continually chase funding for their work. Kelly Dooley's prestigious award from the NIH is intended to help provide respite from that chase. -
September 4, 2024
Bacterial metabolism plays role in staph antibiotic tolerance
Staph is a leading bacterial cause of death from bloodstream, bone and joint infections, in part because of high rates of antibiotic treatment failure. -
July 25, 2024
New study to explore infection response in diabetes
With a $3 million research grant, Henrique Serezani will investigate how altered metabolism in diabetes affects inflammation and sepsis. -
July 23, 2024
VUMC joins $31 million project to speed new TB therapies
Sweeping data integration and clinical trial simulations are needed to help decide which targets to prioritize in researching new tuberculosis treatment regimens.